Taylor Mixides (Drug Target Review)2023-08-11T13:46:14
A new discovery presents a bioinformatic approach for improving vaccine effectiveness against infectious agents such as COVID-19.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
2026-10-28T14:00:00
Sponsored by Miltenyi Biotec
2023-07-11T16:13:06
Sponsored by Agilent
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2024-01-10T08:23:16
Sponsored by BellBrook Labs
Site powered by Webvision Cloud